The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Microbiologics sales in the US from 2017 to 2023, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Smarter leaders trust GlobalData
Microbiologics Inc (Microbiologics) is a manufacturer of laboratory products. The company specializes in contract research organization (CRO), providing laboratory testing services for detecting microbial contamination in water sources, the environment and food products. Its product portfolio includes epower certified reference materials (Epower CRM) microorganism pellets, lyophilized microorganism pellets, microorganisms with green fluorescent protein (GFP), clinical diagnostic control products, pharmaceutical microbiology reference materials, and others. Microbiologics service offerings include antibacterial and antifungal testing, antiviral testing, assay development, custom manufacturing services, proficiency testing solutions, microbial growth and preservation services, and other technical support services. The company partners with the biopharmaceutical companies, manufacturers and suppliers to bring new life-saving anti-infective drugs, vaccines and therapeutics to the market across the world. It operates with its manufacturing, research and development centers in Kalamazoo, Lexington, and San Diego. Microbiologics is headquartered in Saint Cloud, Minnesota, the US. Key subsidiaries of Microbiologics include Gibson Laboratories, Phthisis Diagnostics, Virapur, Cryologics and Micromyx.
The key metrics of Microbiologics related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2023 are shown below:
As Microbiologics is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Microbiologics.
For a detailed understanding of the performance of Microbiologics, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.
